During the first few days of the experiment, the BEV-infected, 6MP-treated mice started to exhibit symptoms indicating the onset of severe disease: ruffled fur, diarrhea, huddling and shuddering, loss of weight, and an increasing lethargy. These symptoms grew progressively worse with the passage of time. Mice started dying after only 3 days, and the mortality rate rose rapidly, from 8 percent after 1 week to 90 percent by the fourth week (see Fig. 1 ). Examination of peritoneal exudate revealed the presence of trophozites as late as 23 days after infection.
In contrast, the 2 groups of control mice (receiving only the 6-MP treatment or the BEV infection) remained in good condition the first week. The second week however saw a loss of weight and some deaths in the BEV controls, following the appearance of ascites in a number of the mice. By the third week, the BEV mice were regaining their lost weight and looked to be in good shape, after day 15. The 6-MP control mice, during the third week, strenuously objected to the last 8 or so injections of the drug, quite the opposite of the 6MP-BEV mice which remained listless and apathetic during and after their daily injections. The 6-MP control mice suffered their crisis during the fourth week, with a sudden loss of weight and heavy mortality amounting to 30 percent of the animals, but after a few days once again went on an upswing. These results can be visualized in Fig. 2 .
Examination of brain smears of the 6MP-BEV mice revealed a few very The format of this experiment was identical to the previous one, with but 1 change. The number of 6-MP injections was reduced from 18 to 11, starting from the day of infection. The results obtained closely paralleled those described for the BEV strain (see Fig. 3 ), but lagged behind by a period of 4 or 5 days, possibly due to the lesser virulence of the S-273 strain. The 6MP-S273 mice started falling visibly ill by day 6, and dying by day 9. At the end of 2 weeks, 45 percent of the mice had died. This figure rose to 75 percent after 3 weeks, and then to 90 percent dead by the end of the fourth week (see Fig. 4 ). Tropho- Consideration was given to the possibility that the 90 percent mortality seen in the 6MP-BEV mice may have been due in part to synergism between the individual effects of the 6-MP and the BEV infection , both of which killed 30 percent of their respective controls. However, in the experiment with the less virulent S-273 strain, the same 90 percent mortality was obtained in the 6MP-S273 mice, even though the control mortality rates had dipped to only 12 percent in the S-273 controls, and to 18 percent in the 6-MP control mice .
Evidence implicating suppression of the immune response as the mechanism of the 6-MP action was provided by the results of the mouse-protection tests , in which all the mice surviving the rigors of the first Toxoplasma infection and 6-MP treatment were challenged with the RH strain . Previous studies (Stahl and Akao, 1964) 
